Augmented local immunity in the liver by a streptococcal preparation, OK432, related to antitumor activity of hepatic macrophages.

[1]  P. P. Jones,et al.  Combined effects of tumor necrosis factor-alpha, prostaglandin E2, and corticosterone on induced Ia expression on murine macrophages. , 1990, Journal of immunology.

[2]  K. Wake,et al.  Ultrastructural study of in vivo tumor cell lysis by liver-associated natural killer cells , 1990 .

[3]  G. Duff,et al.  Interleukin 1: the first interleukin. , 1990, Immunology today.

[4]  S. Cannistra,et al.  Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2. , 1989, Journal of immunology.

[5]  M. Baccarini,et al.  Effect of human recombinant IL-2 on murine macrophage precursors. Involvement of a receptor distinct from the p55 (Tac) protein. , 1989, Journal of immunology.

[6]  C. Dinarello.  Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[7]  E. Wisse,et al.  Tissue localization and kinetics of pit cells or large granular lymphocytes in the liver of rats treated with biological response modifiers , 1988, Hepatology.

[8]  Y. Niitsu,et al.  Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients. , 1988, Immunopharmacology and immunotoxicology.

[9]  D. Laskin,et al.  Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. , 1987, Cancer research.

[10]  L. Old.  Tumour necrosis factor. Polypeptide mediator network. , 1987, Nature.

[11]  T. Shimano,et al.  Induction of tumor necrosis factor by administration of OK-432 in cancer patients. , 1986, Journal of clinical & laboratory immunology.

[12]  R. Philip,et al.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.

[13]  T. Taniguchi,et al.  Molecular Analysis of the Interleukin‐2 System , 1986, Immunological reviews.

[14]  D. A. Flick,et al.  Production of tumor necrosis factor in unprimed mice: mechanism of endotoxin-mediated tumor necrosis. , 1986, Immunobiology.

[15]  R. Grunow,et al.  Recombinant interferon-gamma induces interleukin 2 receptors on human peripheral blood monocytes. , 1986, Journal of immunology.

[16]  K. Matsushima,et al.  There is more than one interleukin 1. , 1986, Immunology today.

[17]  Hoffman Mk.  The effects of tumor necrosis factor on the production of interleukin-1 by macrophages. , 1986 .

[18]  A. Kiderlen,et al.  Liver macrophages (Kupffer cells) as cytotoxic effector cells in extracellular and intracellular cytotoxicity , 1985, Infection and immunity.

[19]  K. Wake,et al.  A striking increase in rod-cored vesicles in pit cells (natural killer cells) and augmentation of the liver-associated natural killer activity by a streptococcal preparation (OK-432) , 1985 .

[20]  S. Cannistra,et al.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells , 1985, The Journal of experimental medicine.

[21]  S. Suzuki,et al.  Augmentation of interleukin 1 and interleukin 2 production by OK-432. , 1985, International journal of immunopharmacology.

[22]  T. Waldmann,et al.  Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells , 1984, Nature.

[23]  M. Tsudo,et al.  Expression of Tac antigen on activated normal human B cells , 1984, The Journal of experimental medicine.

[24]  S. Suzuki,et al.  Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation. , 1984, British Journal of Cancer.

[25]  A. Kirn,et al.  In Vitro Cytostatic Properties of Unactivated Rat Kupffer Cells , 1984, Journal of leukocyte biology.

[26]  T. Iwa,et al.  Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK‐432 , 1984, Cancer.

[27]  M. Suematsu,et al.  Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432. , 1983, Immunopharmacology.

[28]  H. Itoh,et al.  New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. , 1983, Surgery.

[29]  A. Uchida,et al.  In vitro augmentation of natural killing activity by OK-432. , 1981, International journal of immunopharmacology.

[30]  K. Oshimi,et al.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. , 1980, Journal of the National Cancer Institute.

[31]  A. Uchida,et al.  Clinical studies on cell‐mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK‐432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro , 1980 .

[32]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.

[33]  P. Seglen,et al.  Mass isolation and culture of rat kupffer cells , 1975, The Journal of experimental medicine.

[34]  T. Saba.  Physiology and physiopathology of the reticuloendothelial system. , 1970, Archives of internal medicine.

[35]  C. P. Leblond,et al.  IMPROVEMENTS IN THE COATING TECHNIQUE OF RADIOAUTOGRAPHY , 1962 .